HQH vs. HTGC, DNP, ADX, PTY, USA, NUV, GSBD, RVT, TY, and GAB
Should you be buying Abrdn Healthcare Investors stock or one of its competitors? The main competitors of Abrdn Healthcare Investors include Hercules Capital (HTGC), DNP Select Income Fund (DNP), Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), Liberty All-Star Equity Fund (USA), Nuveen Municipal Value Fund (NUV), Goldman Sachs BDC (GSBD), Royce Value Trust (RVT), Tri-Continental (TY), and The Gabelli Equity Trust (GAB). These companies are all part of the "investment offices, not elsewhere classified" industry.
Abrdn Healthcare Investors (NYSE:HQH) and Hercules Capital (NYSE:HTGC) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.
Hercules Capital has a consensus target price of $18.56, suggesting a potential downside of 5.92%. Given Hercules Capital's higher probable upside, analysts clearly believe Hercules Capital is more favorable than Abrdn Healthcare Investors.
Hercules Capital has higher revenue and earnings than Abrdn Healthcare Investors.
In the previous week, Hercules Capital had 6 more articles in the media than Abrdn Healthcare Investors. MarketBeat recorded 8 mentions for Hercules Capital and 2 mentions for Abrdn Healthcare Investors. Hercules Capital's average media sentiment score of 1.08 beat Abrdn Healthcare Investors' score of 0.47 indicating that Hercules Capital is being referred to more favorably in the news media.
Hercules Capital has a net margin of 69.98% compared to Abrdn Healthcare Investors' net margin of 0.00%. Hercules Capital's return on equity of 18.35% beat Abrdn Healthcare Investors' return on equity.
Hercules Capital received 340 more outperform votes than Abrdn Healthcare Investors when rated by MarketBeat users. However, 65.08% of users gave Abrdn Healthcare Investors an outperform vote while only 64.22% of users gave Hercules Capital an outperform vote.
Abrdn Healthcare Investors pays an annual dividend of $1.85 per share and has a dividend yield of 11.2%. Hercules Capital pays an annual dividend of $1.60 per share and has a dividend yield of 8.1%. Hercules Capital pays out 72.7% of its earnings in the form of a dividend.
Abrdn Healthcare Investors has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Hercules Capital has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500.
32.6% of Abrdn Healthcare Investors shares are held by institutional investors. Comparatively, 19.7% of Hercules Capital shares are held by institutional investors. 7.3% of Abrdn Healthcare Investors shares are held by company insiders. Comparatively, 1.9% of Hercules Capital shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Hercules Capital beats Abrdn Healthcare Investors on 10 of the 15 factors compared between the two stocks.
Get Abrdn Healthcare Investors News Delivered to You Automatically
Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abrdn Healthcare Investors Competitors List
Related Companies and Tools
